We are live on
!
Find out more
3C
361 Capital Portfolio holdings
AUM
$213M
1-Year Est. Return
24.26%
This Fund
S&P 500
This Quarter
Est. Return
-20.52%
1 Year Est. Return
+24.26%
3 Year Est. Return
+117.64%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$220M
AUM Growth
-$141M
(-39%)
Cap. Flow
-$75.9M
Cap. Flow
% of AUM
-34.5%
Top 10 Holdings %
Top 10 Hldgs %
7.96%
Holding
421
New
120
Increased
25
Reduced
138
Closed
136
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Williams Companies
WMB
|
+$1.94M |
| 2 |
BERY
Berry Global Group, Inc.
BERY
|
+$1.81M |
| 3 |
TransUnion
TRU
|
+$1.79M |
| 4 |
RenaissanceRe
RNR
|
+$1.76M |
| 5 |
SBNY
Signature Bank
SBNY
|
+$1.71M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Jazz Pharmaceuticals
JAZZ
|
+$2.21M |
| 2 |
PACCAR
PCAR
|
+$2.16M |
| 3 |
Spotify
SPOT
|
+$2.12M |
| 4 |
US Foods
USFD
|
+$2.06M |
| 5 |
ONE Gas
OGS
|
+$1.94M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 16.83% |
| 2 | Healthcare | 15.4% |
| 3 | Industrials | 12.81% |
| 4 | Financials | 12.39% |
| 5 | Real Estate | 6.07% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
76
Cencora
COR
$60.7B
| $875K | 0.4% |
+9,892
| New | +$872K |
|
77
EastGroup Properties
EGP
$11.3B
| $872K | 0.4% |
8,350
-1,982
| -19% | -$250K |
|
78
Theravance Biopharma
TBPH
$873M
| $872K | 0.4% |
+37,754
| New | +$945K |
|
79
Rexford Industrial Realty
REXR
$8.56B
| $870K | 0.4% |
21,203
-5,030
| -19% | -$231K |
|
|
NSA
80
DELISTED
National Storage Affiliates Trust
NSA
| $858K | 0.39% |
29,002
-6,880
| -19% | -$228K |
|
81
MasTec
MTZ
$25.6B
| $853K | 0.39% |
26,049
-3,704
| -12% | -$188K |
|
82
DHT Holdings
DHT
$2.99B
| $850K | 0.39% |
+110,810
| New | +$702K |
|
|
INOV
83
DELISTED
Inovalon Holdings, Inc. Class A Common Stock
INOV
| $849K | 0.39% |
+50,977
| New | +$967K |
|
84
Innoviva
INVA
$1.57B
| $844K | 0.38% |
+71,731
| New | +$949K |
|
85
Halozyme
HALO
$9.88B
| $841K | 0.38% |
46,732
-30,088
| -39% | -$571K |
|
86
Arvinas
ARVN
$536M
| $840K | 0.38% |
+20,841
| New | +$975K |
|
87
Schwab Fundamental Emerging Markets Large Company Index ETF
FNDE
$9.66B
| $840K | 0.38% |
40,854
-2,713
| -6% | -$71.1K |
|
88
Tetra Tech
TTEK
$8.42B
| $840K | 0.38% |
+59,480
| New | +$1.01M |
|
89
Eli Lilly
LLY
$1.03T
| $837K | 0.38% |
6,034
+2,429
| +67% | +$334K |
|
90
Coherus Oncology
CHRS
$227M
| $835K | 0.38% |
51,487
-12,205
| -19% | -$225K |
|
91
Clorox
CLX
$11.7B
| $835K | 0.38% |
+4,822
| New | +$797K |
|
92
American States Water
AWR
$3.37B
| $833K | 0.38% |
+10,195
| New | +$874K |
|
93
Morgan Stanley
MS
$330B
| $823K | 0.37% |
24,193
-6,583
| -21% | -$310K |
|
94
Avista
AVA
$3.39B
| $822K | 0.37% |
19,343
-7,038
| -27% | -$339K |
|
95
Camden Property Trust
CPT
$11.2B
| $821K | 0.37% |
+10,358
| New | +$1.08M |
|
|
ZNGA
96
DELISTED
ZYNGA INC. CL A COMMON
ZNGA
| $821K | 0.37% |
+119,825
| New | +$788K |
|
97
Schwab Fundamental International Large Company Index ETF
FNDF
$25.1B
| $820K | 0.37% |
39,009
+2,381
| +7% | +$61.6K |
|
|
SFBS
98
ServisFirst Bancshares
SFBS
$4.88B
| $813K | 0.37% |
+27,716
| New | +$971K |
|
|
TWNK
99
DELISTED
Hostess Brands, Inc. Class A Common Stock
TWNK
| $813K | 0.37% |
76,255
-18,084
| -19% | -$230K |
|
100
National Beverage
FIZZ
$3B
| $811K | 0.37% |
+38,016
| New | +$831K |
|
Similar funds
SIA
PV
RCM
ALIA
TL
RI
SMFS
HF
361 Capital's Q1 2020 Portfolio in Review
As of Q1 2020, 361 Capital held 421 positions worth $220M, down 39% from $361M the previous quarter. Its ten largest holdings account for 8% of the portfolio.
361 Capital withdrew a net $75.9M in Q1 2020, closing 136 positions and reducing 138 holdings. Its most notable exit was Jazz Pharmaceuticals, an estimated $2.21M position sold in full.
By sector, the portfolio is most concentrated in Technology at 17% of assets, up from 13% a quarter earlier, followed by Healthcare and Industrials.
Against the trend, 361 Capital opened a new position in Williams Companies worth $1.42M.
- 361 Capital's largest Q1 2020 buy was Williams Companies: 100,317 shares worth $1.42M.
- 361 Capital added most to Huntington Ingalls Industries in Q1 2020, an estimated $1.2M increase.
- 361 Capital's biggest Q1 2020 reduction was Zebra Technologies, cutting an estimated $1.52M.
- 361 Capital fully exited Jazz Pharmaceuticals in Q1 2020, selling an estimated $2.21M.
- 361 Capital's ten largest holdings make up 8% of its $220M portfolio in Q1 2020.
- 361 Capital opened 120 new positions and closed 136 in Q1 2020.
- 361 Capital's portfolio value fell 39% quarter-over-quarter to $220M.
Based on 361 Capital's 13F filing for Q1 2020, filed 13 May 2020.